Rockefeller Capital Management
SGMO

Rockefeller Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Rockefeller Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,900
Closed -$1.95K – 4857
2026
Q1 		$1.95K Buy
7,900
+5,000
+172% +$1.99K ﹤0.01% 4414
2025
Q4 		$1.22K Hold
2,900
– – ﹤0.01% 4421
2025
Q3 		$1.95K Buy
+2,900
New +$1.56K ﹤0.01% 4093
2023
Q1 		– Sell
-635
Closed -$1K – 3582
2022
Q4 		$1K Hold
635
– – ﹤0.01% 3753
2022
Q3 		$3K Sell
635
-288
-31% -$1.48K ﹤0.01% 3510
2022
Q2 		$3K Sell
923
-1,112
-55% -$4.81K ﹤0.01% 3690
2022
Q1 		$11K Hold
2,035
– – ﹤0.01% 3008
2021
Q4 		$15K Buy
2,035
+44
+2% +$382 ﹤0.01% 2789
2021
Q3 		$17K Buy
1,991
+1,491
+298% +$14.7K ﹤0.01% 2660
2021
Q2 		$5K Sell
500
-2,500
-83% -$28.3K ﹤0.01% 3042
2021
Q1 		$37K Buy
3,000
+2,900
+2,900% +$39.1K ﹤0.01% 2018
2020
Q4 		$1K Sell
100
-910
-90% -$10.7K ﹤0.01% 2775
2020
Q3 		$9K Hold
1,010
– – ﹤0.01% 2045
2020
Q2 		$9K Buy
1,010
+910
+910% +$8.44K ﹤0.01% 1933
2020
Q1 		$1K Hold
100
– – ﹤0.01% 2306
2019
Q4 		$1K Hold
100
– – ﹤0.01% 2003
2019
Q3 		$1K Buy
+100
New +$1.12K ﹤0.01% 1874

Other funds holding SGMO

NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
AIM
Axiom Investment Management New York $150M AUM
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
HIG
Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Rockefeller Capital Management's SGMO Position: Q2 2026 in Review

Rockefeller Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 7,900 shares — an estimated $1.95K sold.

Rockefeller Capital Management first reported a position in SGMO in Q3 2019 and held it in 17 quarters. The position peaked at $37K in Q1 2021. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

  • Rockefeller Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 7,900 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $1.95K.
  • Rockefeller Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2019 and held it in 17 quarters.
  • Rockefeller Capital Management's SANGAMO THERAPEUTICS INC position peaked at $37K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.